REVIEW
Add like
Add dislike
Add to saved papers

[Pathophysiology of contrast-induced nephropathy].

Contrast-induced nephropathy is one of the major causes of kidney failure in hospitalized patients. Its increased frequency is due to the high number of invasive procedures using contrast media performed for diagnostic or therapeutic purposes in patients with cardiovascular diseases with advanced age and chronic comorbidities such as diabetes and preexisting renal failure. There are two main causes of contrast-induced nephropathy: the direct toxic effect of contrast media on kidney tubules (as shown by morphologic alterations of these cells) and the tissue hypoxia of the renal medulla, secondary to the hemodynamic effects brought about by these agents, consisting in a reduction of vascular resistances. In vulnerable patients, these vasoconstrictor effects are not balanced by an effective vasodilatory reserve and probably by a reduced production of antiapoptotic proteins.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app